发明名称 ALISKIREN AND OROTIC ACID SALT
摘要 FIELD: medicine, pharmaceutics. ^ SUBSTANCE: present invention refers to a new aliskiren and orotic acid salt, preparing and using it, pharmaceutical preparations containing said salt. The aliskiren and orotic acid salt is used to produce a drug preparation used for preventing and treating diseases or conditions which respond to treatment by renin inhibition. A method for preparing the aliskiren and orotic acid salt consists in the fact that (1) aliskiren in the form of a free base and orotic acid are dissolved in an organic solvent, (2) a solvent of the mixed solution is concentrated in heating, at low pressure if required, and slowly cooled to room temperature to boil out and precipitate, (3) the suspension is filtered and dried to prepare the salt. ^ EFFECT: what is produced is the new aliskiren and orotic acid salt showing high physical and chemical stability. ^ 10 cl, 3 tbl, 2 ex
申请公布号 RU2456267(C2) 申请公布日期 2012.07.20
申请号 RU20090121646 申请日期 2007.11.07
申请人 NOVARTIS AG 发明人 REBE ZHAN-LUI;SHTOVASSER FRANK
分类号 A61K31/165;A61P9/12;C07C237/22;C07D239/54 主分类号 A61K31/165
代理机构 代理人
主权项
地址